Lowenstein Sandler represented Indorama Ventures in the transaction. Indorama Ventures (BKK: IVL), a global leader in sustainable chemicals, has entered into an agreement by its Indovinya...
Indorama Ventures’ Acquisition of KEMELIX and FLOWSOLVE
ZOOZ Power’s Business Combination with Keyarch Acquisition Corporation
Lowenstein Sandler, Shibolet & Co. and Maples Group represented ZOOZ Power Ltd. in the transaction. Goldfarb Gross Seligman & Co., Ellenoff Grossman & Schole and Walkers...
Big Health’s Acquisition of Limbix
Lowenstein Sandler represented Big Health in the transaction. Big Health, the leading provider of non-drug digital treatments for mental health, announced the acquisition of Limbix, creators...
Static Media’s Partnership with Novacap Partners
Lowenstein represented Static Media, while Foley & Lardner LLP represented Novacap in the deal. Static Media announced its partnership with Novacap, a leading North American private equity...
BMO’s Acquisition of AIR MILES Reward Program Business from LoyaltyOne
BMO Capital Markets and Morgan Stanley & Co. LLC are acting as financial advisors and Torys LLP and Sullivan & Cromwell LLP are acting as legal...
Titan’s Partnership with Cathie Wood’s ARK Invest to Launch the ARK Venture Fund
Lowenstein Sandler represented Titan in the transaction. Titan announced its newly announced partnership with Cathie Wood’s ARK Invest to launch the ARK Venture Fund, exclusively available...
VTS’ $125 Million Series E Financing Round
Simpson Thacher advised CBRE Group on the deal, while Lowenstein Sandler represented VTS. View the Space, Inc. (VTS), a leading commercial real estate technology platform that...
Crown Laboratories’ Acquisition of Eclipse MedCorp’s Assets
Lowenstein Sandler represented Crown Laboratories in the transaction. Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skincare company, announced its agreement with Eclipse MedCorp LLC,...
VTS’ $200 Million Acquisition of Lane Technologies
Osler, Hoskin & Harcourt and Lowenstein advised VTS on the acquisition of Lane Technologies, assisted by Fasken Martineau DuMoulin LLP. On October 19, 2021, VTS announced...
Crown Laboratories’ Acquisition of StriVectin
Lowenstein advised Hildred Capital Management and Crown Laboratories on the deal, while Gibson, Dunn & Crutcher advised StriVectin and L Catterton. Hildred Capital Management (Hildred) and...
Wesana Health Holdings Inc.’s Acquisition of Psychedelitech Inc.
Cassels Brock & Blackwell LLP and Dorsey & Whitney LLP are acting for Wesana in connection with the Transaction and Garfinkle Biderman LLP and McDonald Hopkins...
Indorama’s $1.3 Billion Acquisition of Ultrapar’s Chemical Unit
Lowenstein, Beccar Varela, and Mattos Filho, Veiga Filho, Marrey Jr. E Quiroga advised Indorama Ventures on the deal. Skadden, Stocche Forbes, BMA – Barbosa, Müssnich, Aragão...